INTERNATIONAL PATENT: PROQR THERAPEUTICS II B.V. FILES APPLICATION FOR "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF POLY-Q DISEASE"

GENEVA, Oct. 18 -- PROQR THERAPEUTICS II B.V. (Zernikedreef 92333 CK Leiden) filed a patent application (PCT/EP2025/059832) for "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF POLY-Q DISEASE" on Apr 10, 2025. With publication no. WO/2025/215130, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KLEIN, Bart (ProQR Therapeutics II B.V.Zernikedreef 92333 CK Leiden), POTMAN, Marko (ProQR Therapeutics II B.V.Zernikedreef 92333 CK Leiden)

Abstract: The disclosure relates to the field of poly-Q diseases such as Huntington's Dise...